Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Osteoarthritis Cartilage. 2013 Feb 4;21(5):655–667. doi: 10.1016/j.joca.2013.01.016

Figure 3.

Figure 3

Threshold efficacy, cost, and life expectancy associated with DMOADs treatment. This figure describes threshold efficacy for alternative willingness-to-pay thresholds, shown in blue ($50,000/QALY), green ($100,000/QALY), and yellow ($150,000/QALY). Squares represent efficacy thresholds for DMOADs costing $1,000/person/year, triangles -- $3,000/person/year, circles -- $5,000/person/year, and diamonds -- $7,000/person/year. The vertical axis shows the per person discounted quality-adjusted life expectancy and the horizontal axis shows the per person discounted lifetime cost. The black square in the lower left corner represents the per person life expectancy and lifetime cost in a program with no DMOADs intervention.